References
- Nousari HC, Kimyai-Asadi A, Caeiro JP, Anhalt GJ. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin: report of 2 cases and review of the literature. Medicine 1999;78:1-8. https://doi.org/10.1097/00005792-199901000-00001
- Neughebauer BI, Negron G, Pelton S, Plunkett RW, Beutner EH, Magnussen R. Bullous skin disease: an unusual allergic reaction to vancomycin. Am J Med Sci 2002;323:273-278. https://doi.org/10.1097/00000441-200205000-00009
- Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994;30:187-192. https://doi.org/10.1016/S0190-9622(94)70015-X
- Vidal C, Gonzalez Quintela A, Fuente R. Toxic epidermal necrolysis due to vancomycin. Ann Allergy 1992;68:345-347.
- Jones DH, Todd M, Craig TJ, et al. Early diagnosis in key in vancomycin-induced linear IgA bullous dermatosis and Steven-Johnson syndrome. J Am Osteopath Assoc 2004;104:157-163.